Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

Clinical trial NCT01652092 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01652092
Sponsor: Masonic Cancer Center, University of Minnesota
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

SCID Omenn's Syndrome Reticular Dysgenesis Wiskott-Aldrich Syndrome Bare Lymphocyte Syndrome Common Variable Immunodeficiency Chronic Granulomatous Disease CD40 Ligand Deficiency Hyper IgM Syndrome X-linked Lymphoproliferative Disease Hemophagocytic Lymphohistiocytosis Griscelli Syndrome

Start date: 2012-09-04
Primary completion: 2025-12-30
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.